BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

Merck Advances Development Programs in Oncology Focusing on Novel Mechanisms and Pathways

New data from DNA Damage Response (DDR) inhibitor portfolio inform development path for this promising biology Clinical trials in locally advanced head ...

June 06, 2022 | News

Merck Invests More Than €440 Million and Expands its Membrane and Filtration Manufacturing in Ireland

Company to invest in two major Life Science projects over five years Significantly increases membrane manufacturing capacities and enables construction ...

May 23, 2022 | News

CanSinoBIO's COVID-19 Vaccine Convidecia™ Receives WHO Emergency Use Listing

In addition to shortening the vaccination cycle by leveraging the advantages of its single-dose regimen, Convidecia™ can be stably transported and st...

May 20, 2022 | News

GenScript Launches GMP Single-Strand and Double-Strand DNA Service for Supporting Gene and Cell Therapy Development

GenScript USA Inc., the world's leading life-science research tools and services provider, announced the availability of new GMP-grade ...

May 17, 2022 | News

What Women Need to Know About Stroke Risks

Cardiovascular disease, including stroke, is the leading cause of death among women, according to the Centers for Disease Control and Prevention (CDC), and...

May 17, 2022 | News

Merck Delivers Strong First Quarter

Results of Q1 2022 Group sales increase by 12.2% to € 5.2 billion; EBITDA pre up 7.8% to € 1.6 billion; EBITDA pre margin 31.3% Growth story ...

May 13, 2022 | News

Avantor® and Cytovance Biologics Collaborate to Accelerate Plasmid DNA Development for Biopharma Customers

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies an...

May 11, 2022 | News

Merck aims to significantly reduce its greenhouse gas emissions by 2030

Merck, a leading science and technology company, aims to significantly reduce its greenhouse gas emissions by 2030. The independent Science Based Targ...

May 10, 2022 | News

Genovac enhances its antibody discovery services with the ENPICOM IGX Platform

Genovac, a leading contract research and manufacturing organization (CRO/CMO) that discovers, develops, and manufactures antibodies for therapeutic, diagno...

May 03, 2022 | News

Biopharmaceuticals: Faster to Market

To combat these challenges, biopharmaceuticals that are produced with the help of living organisms are playing an increasingly important role. However, the...

April 21, 2022 | Opinion

Merck’s ZooMAb® Antibodies Earns First-Ever ACT Label from My Green Lab

ZooMAb® antibodies becomes the first-ever antibody to be recognized for low-environmental impact by My Green Lab ZooMAb® antibodies ra...

April 19, 2022 | News

Agilent Joins AMBIC to Advance Biomanufacturing

Agilent Technologies Inc. (NYSE: A) announced today that it has become a member of the Advanced Mammalian Biomanufacturing Innovation Center (AMB...

April 14, 2022 | News

Merck Advances BioProcessing Capabilities with Acquisition of MAST® Platform from Lonza

Merck to become first company to offer a fully integrated ecosystem for advanced process technologies Brings biopharmaceutical industry closer to digita...

April 14, 2022 | News

Jackson ImmunoResearch announces new range of detection reagents for R&D and diagnostic markets

Jackson ImmunoResearch, manufacturer of secondary antibodies and immunoreagents for the life science market, announces a new range of detection reagents th...

April 13, 2022 | News

Stay Connected